Exactus, Inc.

Published: Nov. 7, 2017, 4:29 p.m.

b"

Is there a faster way to identifying the root cause of a patient's excessive bleeding? Philip Young, President & CEO of Exactus, Inc. (OTCQB: EXDI) explains how the company's Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood are designed to help\\xa0physicians.

"